Ledidi enables secure collaborative medical research across borders

Globally, healthcare systems grapple with balancing data privacy against the need for efficient data sharing to advance medical research and improve patient outcomes. The tension between safeguarding personal information and enabling data-driven healthcare solutions is a common theme across countries. In Norway, for example, researchers face significant hurdles in accessing and effectively utilising the wealth of health data available.

Addressing these issues requires platforms that prioritise both security and usability. One such solution is Ledidi, which enhances health data utilisation while maintaining strict privacy standards in one versatile platform enabling collaboration.

Ledidi is an innovative platform for the management of health research, clinical registries and clinical trials. The solution integrates secure data collection, data analysis, and collaboration tools in a single, user-friendly interface, empowering the global health and life science community to collaborate securely on research in real time.

The cloud-based platform bridges the gap between data protection and accessibility by focusing on both compliance and functionality. Built by AWS state-of-the art technology with privacy-by-design principles, it complies with international data privacy standards such as the EU’s GDPR and the US’s HIPAA regulations. The Ledidi platform also holds ISO 27001, SOC2 and CyberEssentials certifications.

A standout feature is its ability to perform real-time analysis without exposing raw data, preserving confidentiality across teams and borders. Account administrators can customise and assign different permission levels to other colleagues and collaboration partners so everyone has access to the functions they need. Insights and graphs can be analysed without accessing sensitive, personal data.

The platform helps clinicians, researchers and administrators to streamline research workflows, reduce manual tasks, and accelerate time-to-insight through real-time data analysis and collaboration. It can be used for both smaller projects and larger multicentre studies. Data can be captured at scale, and users can also analyse and visualise aggregated data without access to sensitive patient personal data.

Moreover, the platform lowers operational costs by replacing fragmented tools with a single, secure platform. With regard to the environment, its cloud-based design reduces the need for physical infrastructure and paper-based processes. This digital efficiency supports more sustainable research practices and promotes responsible data handling in healthcare.

The global clinical trials market was valued at USD 80.7 billion in 2023 and is projected to reach USD 123.5 billion by 2030, growing at a CAGR of 6.49 per cent from 2024 to 2030.

Ledidi’s target customers are health researchers, hospitals, universities, medical societies, medtech, biotech and pharma companies, and public health institutions. The platform is at a commercial stage, supporting real-world clinical research, registries and clinical trials globally.